Strategic partnerships Kayentis actively pursues partnerships with complementary providers (RWS, Ametris, ClinOne) to enhance eCOA and DCT capabilities, signaling a ripe opportunity to introduce integrated data capture, wearable data, and training services through co-sell motions.

DCT expansion With a global footprint across US, Europe, and Asia and a focus on decentralized clinical trial solutions, there is potential to upsell expanded eCOA platforms, remote data collection, and patient-centric trial offerings to pharma, biotech, and CROs pursuing global DCT strategies.

Wearable integration Recent partnerships aim to combine eCOA with wearable technology to improve adherence and real-world data quality, presenting a sales angle to supply wearable-enabled eCOA workflows and device data integration services.

Growth capital signals Historical growth financing and ongoing investments indicate a scale-up trajectory; this may create doors for larger multi-year contracts, expanded service scopes, and strategic collaborations with potential for joint go-to-market programs.

Mid-market focus Headcount and revenue ranges position Kayentis as a mid-market player similar to peers like CRF Health and Clinovo, suggesting opportunities for targeted mid-size pharma and CROs seeking cost-effective, compliant eCOA and DCT solutions.